Guangji Pharma Planning to Establish Vitamin B6 Production JV.
The construction of the facility is expected to last 18 months. With a total investment of RMB 102.8 million (about USD 15 million), the plant is expected to have a yearly capacity of 1,000 tons and should achieve annual sales of RMB 124 million when fully operational.
The new joint venture for the vitamin B6 project is named Hubei Guanghui Pharmaceutical Co. Ltd with a capital registration of RMB 50 million, 50% from Guangji Pharma; 40% Xianning Jinghui and 10% Hexie Pharma.
Hubei Guangji Pharmaceutical Co. Ltd. has stated that this joint venture has not yet been formally established and is subject to their final approval.
|Printer friendly Cite/link Email Feedback|
|Publication:||Feedinfo News Service|
|Date:||Oct 28, 2009|
|Previous Article:||Philippines - Monterey Foods Corporation Merges With Livestock Firm.|
|Next Article:||Feed-Grade Skim Milk Powder and Whey Production in Selected Countries -- August/September 2009.|